Shinobi Therapeutics
- Biotech or pharma, therapeutic R&D
Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer, autoimmune diseases, and beyond by using immune evasion to unlock the full potential of iPSCs.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}